Literature DB >> 22216861

TET2 and DNMT3A mutations in human T-cell lymphoma.

Lucile Couronné, Christian Bastard, Olivier A Bernard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22216861     DOI： 10.1056/NEJMc1111708

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  173 in total

1.  Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.

Authors:  Madhu P Menon; Alina Nicolae; Hillary Meeker; Mark Raffeld; Liqiang Xi; Armin G Jegalian; Douglas C Miller; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

2.  A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients.

Authors:  Seung Ho Lee; Ji Sun Kim; Jaesang Kim; Seok Jin Kim; Won Seog Kim; Sanghyuk Lee; Young Hyeh Ko; Hae Yong Yoo
Journal:  Haematologica       Date:  2015-09-24       Impact factor: 9.941

3.  Guest editorial: pre‑leukemia/pre‑lymphoma—what is old, what is new?

Authors:  Shigeru Chiba
Journal:  Int J Hematol       Date:  2015-11       Impact factor: 2.490

Review 4.  Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma.

Authors:  Russell James Hubbard Ryan; Ryan Alan Wilcox
Journal:  Hematol Oncol Clin North Am       Date:  2019-05-18       Impact factor: 3.722

5.  A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.

Authors:  Oreofe Odejide; Oliver Weigert; Andrew A Lane; Dan Toscano; Matthew A Lunning; Nadja Kopp; Sunhee Kim; Diederik van Bodegom; Sudha Bolla; Jonathan H Schatz; Julie Teruya-Feldstein; Ephraim Hochberg; Abner Louissaint; David Dorfman; Kristen Stevenson; Scott J Rodig; Pier Paolo Piccaluga; Eric Jacobsen; Stefano A Pileri; Nancy L Harris; Simone Ferrero; Giorgio Inghirami; Steven M Horwitz; David M Weinstock
Journal:  Blood       Date:  2013-12-17       Impact factor: 22.113

Review 6.  Advances in targeted therapy for malignant lymphoma.

Authors:  Li Wang; Wei Qin; Yu-Jia Huo; Xiao Li; Qing Shi; John E J Rasko; Anne Janin; Wei-Li Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-03-06

7.  A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.

Authors:  Hae Yong Yoo; Min Kyung Sung; Seung Ho Lee; Sangok Kim; Haeseung Lee; Seongjin Park; Sang Cheol Kim; Byungwook Lee; Kyoohyoung Rho; Jong-Eun Lee; Kwang-Hwi Cho; Wankyu Kim; Hyunjung Ju; Jaesang Kim; Seok Jin Kim; Won Seog Kim; Sanghyuk Lee; Young Hyeh Ko
Journal:  Nat Genet       Date:  2014-03-02       Impact factor: 38.330

8.  RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis.

Authors:  Jose R Cortes; Alberto Ambesi-Impiombato; Lucile Couronné; S Aidan Quinn; Christine S Kim; Ana C da Silva Almeida; Zachary West; Laura Belver; Marta Sanchez Martin; Laurianne Scourzic; Govind Bhagat; Olivier A Bernard; Adolfo A Ferrando; Teresa Palomero
Journal:  Cancer Cell       Date:  2018-02-02       Impact factor: 31.743

9.  Paradoxical association of TET loss of function with genome-wide DNA hypomethylation.

Authors:  Isaac F López-Moyado; Ageliki Tsagaratou; Hiroshi Yuita; Hyungseok Seo; Benjamin Delatte; Sven Heinz; Christopher Benner; Anjana Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-01       Impact factor: 11.205

10.  Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.

Authors:  Jonathan E Sandoval; Yung-Hsin Huang; Abigail Muise; Margaret A Goodell; Norbert O Reich
Journal:  J Biol Chem       Date:  2019-01-31       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.